Magnitude Biosciences started operations in September 2018 to commercialise a Durham University ageing research technology centred on the C.elegans nematode worm.
Magnitude Biosciences, a UK-based ageing research company spun out of Durham University, yesterday received £150,000 ($194,000) in a round featuring the EU-backed North East Innovation Fund.
Saker Capital, a speciality real estate investment and advisory firm, also supplied Magnitude with funding.
Founded in September 2018, Magnitude Biosciences is progressing research into compounds such as food additives and drugs with the potential to affect the ageing process.
Magnitude Biosciences utilises an automated “healthspan” machine which samples large quantities…
